Challenge

In 2020, after falling short in the COVID vaccine race and going through a major restructure, GSK set out to transform its culture and protect its position as a world-leading pharmaceutical company.

Solution


We partnered with the CEO and C-suite to define GSK’s EVP around its new purpose: Get ahead of disease together. We optimised ways of working across 70,000+ employees to build a more resilient, high-impact culture.